(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;angiotensin III, 1-desarginine-;Ang IV, Angiotensin II (3-8);Angiotensin IV trifluoroacetate salt;Angiotensin IV trifluoroacetate
Angiotensin II (3-8), human is a slightly less potent agonist of the angiotensin AT1 receptor; it induces endothelium-dependent renal cortical vasodilation in anesthetized rats; at doses up to 125 pmol/kg, it shows no cardiovascular effects, whereas at doses of 1.25 and 12.5 nmol/kg, it causes dose-dependent increases in mean arterial blood pressure and reductions in renal and mesenteric blood flows and vascular conductances.